Search Results - "Cobb, Carla"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Board-Certified Psychiatric Pharmacists and Their Potential Role in Addressing Behavioral Health Workforce Shortages by Cobb, Carla D, Puzantian, Talia, Shuman, Michael

    Published in Psychiatric services (Washington, D.C.) (01-10-2024)
    “…Board-certified psychiatric pharmacists (BCPPs) are doctorate-level, board-certified experts in managing medications for people living with psychiatric…”
    Get full text
    Journal Article
  2. 2

    Optimizing Medication Use with a Pharmacist-Provided Comprehensive Medication Management Service for Patients with Psychiatric Disorders by Cobb, Carla D.

    Published in Pharmacotherapy (01-12-2014)
    “…Our objective was to evaluate a pharmacist‐delivered comprehensive medication management (CMM) service provided to patients with psychiatric disorders. We…”
    Get full text
    Journal Article
  3. 3

    Systematic literature review of the impact of psychiatric pharmacists by Ho, Jessica L, Roberts, Jenna, Payne, Gregory H, Holzum, Dorothy N, Wilkoff, Hannah, Tran, Tran, Cobb, Carla D, Moore, Tera D, Lee, Kelly C

    Published in The mental health clinician (01-02-2024)
    “…Pharmacists focusing on psychotropic medication management and practicing across a wide variety of healthcare settings have significantly improved…”
    Get full text
    Journal Article
  4. 4

    Social Determinants of Health in People Living with Psychiatric Disorders: The Role of Pharmacists by Cobb, Carla D, Allen, Shari N, Cusimano, Joseph M, Ding, Michelle, Eloma, Amanda S, Ott, Carol A, Tallian, Kimberly B

    Published in Health equity (01-04-2023)
    “…Social determinants of health (SDOH) affect outcomes of people living with psychiatric disorders, including substance use disorders. As experts in medication…”
    Get full text
    Journal Article
  5. 5

    Survey of prescriptive authority among psychiatric pharmacists in the United States by Lee, Kelly C, Silvia, Richard J, Cobb, Carla D, Moore, Tera D, Payne, Gregory H

    Published in The mental health clinician (01-03-2021)
    “…Despite the high prevalence of those with mental illnesses, there is a critical shortage of psychiatric providers in the United States. Psychiatric pharmacists…”
    Get full text
    Journal Article
  6. 6

    Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements by Silvia, Richard J, Lee, Kelly C, Payne, Gregory H, Ho, Jessica, Cobb, Carla, Ansara, Elayne D, Ross, Clint A

    Published in The mental health clinician (01-04-2022)
    “…A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes…”
    Get full text
    Journal Article
  7. 7

    Assessment of the current practice of psychiatric pharmacists in the United States by Silvia, Richard J, Lee, Kelly C, Bostwick, Jolene R, Cobb, Carla D, Goldstone, Lisa W, Moore, Tera D, Payne, Gregory H, Ho, Jessica L

    Published in The mental health clinician (01-11-2020)
    “…A comprehensive review of psychiatric pharmacy practice has never been performed in the United States. As psychiatric pharmacists become more involved in…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Comprehensive medication management for patients with mental illnesses by Cobb, Carla

    Published in The mental health clinician (01-10-2013)
    “…Comprehensive medication management (CMM) is a patient-care practice that aims to ensure that a patient's medication therapy is effective and safe. This…”
    Get full text
    Journal Article
  10. 10

    Development of the Core Outcome Set for Psychiatric Pharmacists by Reinstatler, Kristina, Payne, Gregory H., Lister, Jonathan F., Moore, Tera D., Parmentier, Brittany L., Santos, Ranel Troy, Cobb, Carla D.

    “…Objective The American Association of Psychiatric Pharmacists (AAPP) sought to develop a consensus‐based set of outcomes and measures to standardize…”
    Get full text
    Journal Article
  11. 11

    Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders by Werremeyer, Amy, Bostwick, Jolene, Cobb, Carla, Moore, Tera D, Park, Susie H, Price, Cristofer, McKee, Jerry

    Published in The mental health clinician (01-11-2020)
    “…Psychiatric and neurologic illnesses are highly prevalent and are often suboptimally treated. A 2015 review highlighted the value of psychiatric pharmacists in…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Duloxetine (Cymbalta) for Treatment of Major Depressive Disorder by Cobb, Carla, Crichlow, Renee

    Published in American family physician (15-09-2005)
    “…Duloxexetine is a serotonin and norepinephrine reuptake inhibitor in the same class as venlafaxine. It is approved by the US Food and Drug Administration for…”
    Get full text
    Journal Article